Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2012 Results
Date:5/8/2012

and administrative (G&A) expenses are expected to be between $13.0 and $15.0 million.  This compares to $11.5 million in 2011 and includes approximately $2.0 to $4.0 million in commercial expenses for pre-launch preparation for tasimelteon in the treatment of Non-24.  G&A expenses include approximately $3.0 million of stock based compensation (SBC).  Excluding SBC, G&A expenses are expected to be between $10.0 and $12.0 million.
  • Research and development (R&D) expenses are expected to be between $42.0 and $47.0 million.  This compares to $29.0 million in 2011.  The increase of $13 to $18 million over 2011 reflects our ongoing investment in the development of tasimelteon for Non-24 and MDD.  R&D expenses include approximately $2.5 million of SBC.  Excluding SBC, R&D expenses are expected to be between $39.5 and $44.5 million. 
  • Total GAAP operating expenses are expected to be between $57.0 and $64.0 million.  This includes Fanapt® cost of sales of $1.5 million related to amortization of an intangible asset and $5.0 to $6.0 million of SBC.
  • Full year change in cash is expected to be between $45.0 and $50.0 million. 
  • The tables at the end of this press release include a reconciliation of GAAP to non-GAAP expected G&A expenses and R&D expenses. An explanation of these measures is also included below under the heading "Use of Non-GAAP Financial Measures."

    CONFERENCE CALLVanda has scheduled a conference call for today, Tuesday, May 8, 2012, at 10:00 AM ET.  During the call, Vanda's management will discuss the first quarter 2012 results and other corporate activities.  Investors can call 866-314-4865 (domestic) and 617-213-8050 (international) and use passcode 62288061.  A replay of the call will be available beginning Tuesday, May 8, 2012 at 12:00 PM ET and will be accessible until Tuesday, May 15, 2012, at 5:00 PM ET. 
    '/>"/>

    SOURCE Vanda Pharmaceuticals Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
    2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
    3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
    4. Vanda Presents Phase III Iloperidone Efficacy Data
    5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
    6. Vanda Pharmaceuticals Provides Update on Iloperidone
    7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
    8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
    9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
    10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
    11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... 2014  Lockton Dunning Benefits, the ... the addition of Vice President Kim Foerster ... Pharmacy Consulting team, Excelsior Solutions. ... to the position.  Most recently, she worked as ... Specialty Pharmacy, where she has held various managerial ...
    (Date:12/24/2014)... Dec. 23, 2014 In response to urgent requests ... Sierra Leone , Direct Relief delivered two ... for the treatment of local health workers who contract Ebola ... dedicated Ebola care center was constructed for foreign health care ... not available for local Sierra Leonean health workers. ...
    (Date:12/22/2014)... N.J. , Dec. 22, 2014  CytoSorbents ... marketing its CytoSorb® blood purification technology to help ... patients in 28 countries worldwide, today announced the ... , MD, FACS, as its Senior Vice President ... Dr. Di Russo is ...
    Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
    ... 24, 2011 Christiana Care Health System,s Helen ... clinical trial to determine if Crestor® (Rosuvastatin), a cholesterol-lowering ... colon cancer surgery. (Logo: http://photos.prnewswire.com/prnh/20090407/DC95299LOGO ) ... Crestor can stop the growth of tumor cells by ...
    ... important role oncology practitioners and patient support groups play ... of radiation therapy technology to treat cancer, honored select ... on March 23, 2011 at the Ritz-Carlton in Phoenix. ... in which residents of Phoenix and the surrounding areas ...
    Cached Medicine Technology:Christiana Care Health System Leads National Colorectal Cancer Clinical Trial 2Elekta-sponsored Ceremony Honors Arizona Cancer Heroes 2Elekta-sponsored Ceremony Honors Arizona Cancer Heroes 3
    (Date:12/25/2014)... This is a professional and in-depth ... industry with a focus on the Chinese market. The ... the Sterilizers manufacturers and is a valuable source of ... the industry. This report provides a basic overview of ... In this part, the report presents the company profile, ...
    (Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... of the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ... Liebhard LLP reports. According to an Order issued in ... November 20th, the Court will convene an open conference ... Federal Building and United States Courthouse in West Palm ...
    (Date:12/25/2014)... CA (PRWEB) December 25, 2014 The short ... was created in honor of a true 9/11 hero, ... two film festivals including the 24 hours of Nuremberg International ... in Bangladesh. , Actress, screenwriter and director Luciana ... produce this film together with her husband, Gregory Graham ...
    (Date:12/25/2014)... When head lice hits a home or ... to get rid of it while keeping it from taking ... now have the solution right in their neighborhood: Lice ... Troopers provides full spectrum head lice screening and treatment services ... Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South ...
    (Date:12/25/2014)... -- Overeating is common during the holidays, but there are ... says. "Don,t arrive at a party hungry. It may ... be attending a party, but deprivation leads to hunger, and ... Westchester Hospital in Mount Kisco, N.Y., said in a hospital ... day and even to have a snack before attending a ...
    Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
    ... kills a type of brain tumor.// ,A strain of ... which is one of the deadliest forms of brain tumors. ... to modern medical or surgical procedures. ,Researchers of Yale ... viruses through a series of tests to find out the ...
    ... Researchers from Netherlands have found out that certain ordinary ... cardiac arrest. ,The new study, which was published ... drugs interfere with the electrical activity controlling heartbeats that ... ,These drugs are those that can prolong the duration ...
    ... report done by Swedish scientists its said that it is ... prostate cancer than to wait and see if the disease ... prostatectomy, is a common procedure. The researchers had conducted he ... prostate cancer benefits the patients more than watching and waiting ...
    ... first test that// uses DNA in blood to diagnose cystic fibrosis. ... can analyze DNA samples from the blood and detect genes that ... adults. The test can not only predict the advent of the ... are not having the disease but are the carriers of the ...
    ... Italian researchers says that how long women can stay fertile may ... says that when the women will enter their menopause may also ... had looked into the data collected from nearly 3000 postmenopausal women ... journal Human Reproduction. ,The results of the study show that ...
    ... diseases and recent study says that// cocaine abuse can lead ... on to find out the effect of substance abuse on ... to find out the effect of cocaine abuse on the ... coronary angiography, there was evidence of heart aneurysms. ,Aneurysm ...
    Cached Medicine News:
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: